O	0	7	Effects	Effect	NNS	B-NP
O	8	10	of	of	IN	B-PP
O	11	12	4	4	CD	B-NP
O	12	13	-	-	HYPH	I-NP
O	13	28	alkylmorpholine	alkylmorpholine	NN	I-NP
O	29	30	N	N	NN	I-NP
O	30	31	-	-	HYPH	O
O	31	37	oxides	oxide	NNS	B-NP
O	38	40	on	on	IN	B-PP
O	41	44	ATP	ATP	NN	B-NP
O	44	45	-	-	HYPH	O
O	45	54	producing	produce	VBG	B-VP
O	55	64	processes	process	NNS	B-NP
O	65	67	in	in	IN	B-PP
B-Cell	68	75	Ehrlich	Ehrlich	NNP	B-NP
I-Cell	76	83	ascites	ascite	NNS	I-NP
O	84	87	and	and	CC	O
B-Cell	88	93	L1210	L1210	NN	B-NP
I-Cell	94	103	leukaemia	leukaemia	NN	I-NP
I-Cell	104	109	cells	cell	NNS	I-NP
O	109	110	.	.	.	O

O	111	114	The	The	DT	B-NP
O	115	119	main	main	JJ	I-NP
O	120	127	purpose	purpose	NN	I-NP
O	128	130	of	of	IN	B-PP
O	131	134	the	the	DT	B-NP
O	135	142	present	present	JJ	I-NP
O	143	156	investigation	investigation	NN	I-NP
O	157	160	was	be	VBD	B-VP
O	161	163	to	to	TO	B-VP
O	164	169	study	study	VB	I-VP
O	170	173	the	the	DT	B-NP
O	174	180	effect	effect	NN	I-NP
O	181	183	of	of	IN	B-PP
O	184	187	the	the	DT	B-NP
O	188	198	homologous	homologous	JJ	I-NP
O	199	205	series	series	NN	I-NP
O	206	208	of	of	IN	B-PP
O	209	210	4	4	CD	B-NP
O	210	211	-	-	HYPH	I-NP
O	211	226	alkylmorpholine	alkylmorpholine	NN	I-NP
O	227	228	N	N	NN	I-NP
O	228	229	-	-	HYPH	O
O	229	235	oxides	oxide	NNS	B-NP
O	236	238	on	on	IN	B-PP
O	239	242	ATP	ATP	NN	B-NP
O	242	243	-	-	HYPH	O
O	243	252	producing	produce	VBG	B-VP
O	253	262	processes	process	NNS	B-NP
O	263	265	in	in	IN	B-PP
B-Cell	266	273	Ehrlich	Ehrlich	NNP	B-NP
I-Cell	274	281	ascites	ascite	NNS	I-NP
O	282	285	and	and	CC	O
B-Cell	286	291	L1210	L1210	NN	B-NP
I-Cell	292	298	murine	murine	JJ	I-NP
I-Cell	299	308	leukaemia	leukaemia	NN	I-NP
I-Cell	309	314	cells	cell	NNS	I-NP
O	314	315	.	.	.	O

O	316	319	The	The	DT	B-NP
O	320	327	effects	effect	NNS	I-NP
O	328	330	on	on	IN	B-PP
O	331	338	aerobic	aerobic	JJ	B-NP
O	339	346	glucose	glucose	NN	I-NP
O	347	358	consumption	consumption	NN	I-NP
O	358	359	,	,	,	O
O	360	366	lactic	lactic	JJ	B-NP
O	367	371	acid	acid	NN	I-NP
O	372	381	formation	formation	NN	I-NP
O	381	382	,	,	,	O
O	383	390	content	content	NN	B-NP
O	391	393	of	of	IN	B-PP
O	394	399	total	total	NN	B-NP
O	400	401	(	(	(	I-NP
O	401	402	T	T	NN	I-NP
O	402	403	-	-	HYPH	I-NP
O	403	405	SH	SH	NN	I-NP
O	405	406	)	)	)	O
O	407	410	and	and	CC	O
O	411	414	non	non	AFX	B-NP
O	414	415	-	-	HYPH	I-NP
O	415	422	protein	protein	NN	I-NP
O	423	428	thiol	thiol	NN	I-NP
O	429	435	groups	group	NNS	I-NP
O	436	437	(	(	(	O
O	437	439	NP	NP	NN	B-NP
O	439	440	-	-	HYPH	O
O	440	442	SH	SH	NN	B-NP
O	442	443	)	)	)	O
O	443	444	,	,	,	O
O	445	455	endogenous	endogenous	JJ	B-NP
O	456	459	and	and	CC	I-NP
O	460	469	exogenous	exogenous	JJ	I-NP
O	470	481	respiration	respiration	NN	I-NP
O	482	485	and	and	CC	O
O	486	489	the	the	DT	B-NP
O	490	495	level	level	NN	I-NP
O	496	498	of	of	IN	B-PP
O	499	502	ATP	ATP	NN	B-NP
O	503	505	in	in	IN	B-PP
B-Cell	506	512	tumour	tumour	NN	B-NP
I-Cell	513	518	cells	cell	NNS	I-NP
O	519	528	incubated	incubate	VBN	B-VP
O	529	531	in	in	FW	B-ADVP
O	532	537	vitro	vitro	FW	I-ADVP
O	538	542	were	be	VBD	B-VP
O	543	555	investigated	investigate	VBN	I-VP
O	555	556	.	.	.	O

O	557	558	4	4	CD	B-NP
O	558	559	-	-	HYPH	I-NP
O	559	576	Dodecylmorpholine	Dodecylmorpholine	NN	I-NP
O	577	578	N	N	NN	I-NP
O	578	579	-	-	HYPH	O
O	579	584	oxide	oxide	NN	B-NP
O	585	586	(	(	(	O
O	586	590	DMNO	DMNO	NN	B-NP
O	590	591	)	)	)	O
O	591	592	,	,	,	O
O	593	596	one	one	CD	B-NP
O	597	599	of	of	IN	B-PP
O	600	603	the	the	DT	B-NP
O	604	608	most	most	RBS	I-NP
O	609	615	active	active	JJ	I-NP
O	616	625	compounds	compound	NNS	I-NP
O	625	626	,	,	,	O
O	627	636	decreased	decrease	VBD	B-VP
O	637	640	the	the	DT	B-NP
O	641	646	level	level	NN	I-NP
O	647	649	of	of	IN	B-PP
O	650	653	ATP	ATP	NN	B-NP
O	654	665	immediately	immediately	RB	B-ADVP
O	666	671	after	after	IN	B-PP
O	672	680	addition	addition	NN	B-NP
O	681	683	to	to	TO	B-PP
O	684	687	the	the	DT	B-NP
O	688	698	suspension	suspension	NN	I-NP
O	699	701	of	of	IN	B-PP
B-Cell	702	709	Ehrlich	Ehrlich	NN	B-NP
I-Cell	710	715	cells	cell	NNS	I-NP
O	716	718	in	in	IN	B-PP
O	719	721	an	an	DT	B-NP
O	722	725	ice	ice	NN	I-NP
O	726	730	bath	bath	NN	I-NP
O	730	731	.	.	.	O

O	732	737	After	After	IN	B-PP
O	738	739	2	2	CD	B-NP
O	740	741	h	h	NN	I-NP
O	742	752	incubation	incubation	NN	I-NP
O	753	755	at	at	IN	B-PP
O	756	758	37	37	CD	B-NP
O	759	766	degrees	degree	NNS	I-NP
O	767	768	C	C	JJ	B-ADJP
O	769	772	the	the	DT	B-NP
O	773	777	drop	drop	NN	I-NP
O	778	780	in	in	IN	B-PP
O	781	784	the	the	DT	B-NP
O	785	788	ATP	ATP	NN	I-NP
O	789	794	level	level	NN	I-NP
O	795	798	was	be	VBD	B-VP
O	799	803	much	much	RB	B-ADJP
O	804	809	lower	low	JJR	I-ADJP
O	809	810	.	.	.	O

O	811	812	A	A	DT	B-NP
O	813	821	possible	possible	JJ	I-NP
O	822	833	explanation	explanation	NN	I-NP
O	834	837	for	for	IN	B-PP
O	838	841	the	the	DT	B-NP
O	842	850	decrease	decrease	NN	I-NP
O	851	853	in	in	IN	B-PP
O	854	857	the	the	DT	B-NP
O	858	861	ATP	ATP	NN	I-NP
O	862	867	level	level	NN	I-NP
O	868	873	might	might	MD	B-VP
O	874	876	be	be	VB	I-VP
O	877	888	interaction	interaction	NN	B-NP
O	889	891	of	of	IN	B-PP
O	892	895	the	the	DT	B-NP
O	896	901	amine	amine	NN	I-NP
O	902	907	oxide	oxide	NN	I-NP
O	908	912	with	with	IN	B-PP
O	913	916	the	the	DT	B-NP
B-Cellular_component	917	921	cell	cell	NN	I-NP
I-Cellular_component	922	930	membrane	membrane	NN	I-NP
O	930	931	.	.	.	O

